Article Information
History
- September 27, 2018.
Article Versions
- You are currently viewing Version 1 of this article (September 27, 2018 - 07:22).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Izaskun Mallona1,*,$,
- Susanna Aussó2,
- Anna Díez-Villanueva1,2,
- Víctor Moreno2 and
- Miguel A. Peinado1,*
- 1Health Research Institute Germans Trias i Pujol (IGTP), Program in Predictive and Personalized Medicine of Cancer. Badalona, Spain.
- 2Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L’Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
- ↵*Correspondence:
Miguel A. Peinado, email: mpeinado{at}igtp.cat (Lead contact), Izaskun Mallona, email: izaskun.mallona{at}gmail.com